Eric Cohen
| Éric A. Cohen | |
|---|---|
| Born | March 19, 1958 |
| Residence | Montréal, QC, Canada |
| Citizenship | Canadian |
| Fields |
HIV Research Virology Molecular Biology |
| Institutions |
Institut de recherches cliniques de Montréal (IRCM) Université de Montréal McGill University |
| Alma mater |
Collège Jean-de-Brébeuf McGill University Université de Montréal Dana-Farber Cancer Institute, Havard Medical School |
Éric A. Cohen (born March 19, 1958) is a Canadian molecular virologist whose research is focused on human immunodeficiency virus (HIV)-host interactions that govern viral replication and persistence.
Cohen graduated from Collège Jean-de-Brébeuf of Montréal in 1977 with a college diploma in Health Sciences. He received a B.Sc. in Biochemistry from McGill University in 1981 and a Ph.D. in Molecular Biology from Université de Montréal in 1987.
As a Ph.D. student, he worked on fundamental aspects of herpes simplex virus replication and transformation under the direction of Yves Langelier. In 1986, he joined the laboratory of William A. Haseltine at the Dana-Farber Cancer Institute and Harvard Medical School as a postdoctoral fellow, working on fundamental aspects of HIV structure and function to uncover new targets for antiviral therapy. His postdoctoral work led to the identification of two HIV-1 non-structural proteins, named Viral Protein U (Vpu) and Viral Protein R (Vpr), part of a new class of retroviral proteins - designated accessory proteins - that are required for optimal virus multiplication and dissemination.
In 1990, Cohen became a Faculty member of the Department of Microbiology, Infectiology and Immunology at Université de Montréal and was appointed Professor of Virology in 1999. In 2004, he joined the Institut de recherches cliniques de Montréal, where he is currently pursuing research aimed at understanding HIV persistence and identifying intervention strategies for an HIV cure.
Cohen’s laboratory has contributed to describing the structure and function of Vpr during HIV-1 infection. His work was also involved in defining Vpr as a viral factor with immune-modulatory functions.
...
Wikipedia